Morning After is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Rapha Pharmaceuticals, Inc.. The primary component is Levonorgestrel.
Product ID | 69953-517_f0fabe80-87bc-9b65-e053-2995a90a582b |
NDC | 69953-517 |
Product Type | Human Otc Drug |
Proprietary Name | Morning After |
Generic Name | Levonorgestrel |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2022-12-30 |
Marketing Category | ANDA / |
Application Number | ANDA205329 |
Labeler Name | Rapha Pharmaceuticals, Inc. |
Substance Name | LEVONORGESTREL |
Active Ingredient Strength | 2 mg/1.5mg |
Pharm Classes | Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
NDC | Brand Name | Generic Name |
---|---|---|
69953-515 | Morning After | Morning After |
69953-514 | Morning After | Morning After |
50102-111 | EContra EZ | levonorgestrel |
50102-211 | EContra One-Step | Levonorgestrel |
50419-424 | Kyleena | Levonorgestrel |
0536-1142 | Levonorgestrel | Levonorgestrel |
40032-620 | Levonorgestrel | Levonorgestrel |
40032-622 | Levonorgestrel | Levonorgestrel |
40051-054 | LEVONORGESTREL | levonorgestrel |
49615-017 | Levonorgestrel | Levonorgestrel |
0023-5858 | LILETTA | Levonorgestrel |
50419-423 | Mirena | Levonorgestrel |
43386-620 | My Way | Levonorgestrel |
43386-622 | My Way | Levonorgestrel |
16714-809 | New Day | levonorgestrel |
21695-443 | NEXT CHOICE | Levonorgestrel |
0113-2003 | Option 2 | levonorgestrel |
21695-973 | Plan B One-Step | levonorgestrel |
50090-1141 | Plan B One-Step | Levonorgestrel |
50090-3830 | Plan B One-Step | levonorgestrel |
50090-5978 | Plan B One-Step | levonorgestrel |
11509-0067 | Preventeza | levonorgestrel |
50419-422 | Skyla | Levonorgestrel |